Insider Trading activities at Crispr Therapeutics Ag (CRSP)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Crispr Therapeutics Ag (CRSP) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Crispr Therapeutics Ag. Table 2 shows the detailed insider transactions. This company's CIK number is 1674416.

Total stock buying since 2016: $293,942,208.
Total stock sales since 2016: $373,417,799.
Total stock option exercises since 2016: $19,239,965.


 1   2   3 
25 insiders reported insider trading activities at Crispr Therapeutics Ag (CRSP):
Insider trading activities of Klein Lawrence Otto
Insider trading activities of Smith Brendan
Insider trading activities of Treco Douglas A
Insider trading activities of Bruno Julianne
Insider trading activities of Dylan-hyde Tyler
Insider trading activities of Tomsicek Michael John
Insider trading activities of Glaxosmithkline Plc
Insider trading activities of George Simeon
Insider trading activities of Versant Venture Capital V (canada), Lp
Insider trading activities of Woiwode Thomas
Insider trading activities of Cagnoni Pablo J
Insider trading activities of Bayer Global Investments B.v.
Insider trading activities of Patel Naimish
Insider trading activities of Celgene Corp /de/
Insider trading activities of Prasad Raju
Insider trading activities of Kasinger James R.
Insider trading activities of Bolzon Bradley J Phd
Insider trading activities of Emster Kurt Von
Insider trading activities of Vertex Pharmaceuticals Inc / Ma
Insider trading activities of Morrow Phuong Khanh
Insider trading activities of Lundberg Sven Ante
Insider trading activities of Ho Tony W
Insider trading activities of Kulkarni Samarth
Insider trading activities of Novak Rodger
Insider trading activities of Greene John

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Crispr Therapeutics Ag (CRSP).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 4,976,060 $258,954,140 124,854 $6,280,789 157,497 $0
2024 0 $0 213,469 $13,804,447 210,103 $2,477,607
2023 0 $0 125,000 $6,506,300 178,754 $2,390,000
2022 0 $0 150,000 $9,148,625 292,152 $2,545,901
2021 0 $0 398,877 $62,188,865 382,267 $2,802,515
2020 0 $0 963,688 $100,088,841 493,985 $6,475,496
2019 0 $0 459,118 $21,805,542 141,618 $778,761
2018 724,346 $16,626,368 2,353,910 $113,098,938 185,500 $1,065,394
2017 0 $0 2,185,156 $40,495,452 285,421 $704,291
2016 1,311,550 $18,361,700 0 $0 0 $0

Table 2. Monthly summary of insider trading at Crispr Therapeutics Ag (CRSP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 20,000 $1,140,600 13,081 $760,660 25,000 $0
2025-07 4,949,060 $257,499,590 0 $0 0 $0
2025-05 0 $0 3,932 $141,316 10,000 $0
2025-03 0 $0 40,678 $1,708,034 84,772 $0
2025-02 7,000 $313,950 67,163 $3,670,779 37,725 $0
2024-12 0 $0 15,000 $826,560 0 $0
2024-11 0 $0 30,000 $1,675,500 0 $0
2024-10 0 $0 5,382 $249,078 10,446 $0
2024-06 0 $0 3,366 $188,798 7,000 $0
2024-04 0 $0 19,582 $1,177,681 19,582 $374,407
2024-03 0 $0 41,856 $3,119,235 66,000 $382,400
2024-02 0 $0 28,283 $2,277,485 37,075 $382,400
2024-01 0 $0 70,000 $4,290,110 70,000 $1,338,400
2023-05 0 $0 25,000 $1,628,350 31,938 $478,000
2023-04 0 $0 25,000 $1,274,350 25,000 $478,000
2023-03 0 $0 25,000 $1,114,475 50,916 $478,000
2023-02 0 $0 25,000 $1,212,350 45,900 $478,000
2023-01 0 $0 25,000 $1,276,775 25,000 $478,000
2022-12 0 $0 25,000 $1,028,350 129,900 $583,401
2022-11 0 $0 25,000 $1,365,275 25,000 $478,000
2022-10 0 $0 0 $0 3,750 $0
2022-09 0 $0 25,000 $1,619,350 25,000 $405,250
2022-08 0 $0 25,000 $1,672,975 25,000 $405,250
2022-07 0 $0 25,000 $1,915,850 25,000 $359,750

Table 3. Detailed insider trading at Crispr Therapeutics Ag (CRSP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-18 Kulkarni Samarth (Chief Executive Officer) Sale 13,081 58.15 760,660
2025-08-16 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 .00 0
2025-08-06 Treco Douglas A Buy 20,000 57.03 1,140,600
2025-07-16 George Simeon Buy 2,969,436 52.03 154,499,754
2025-05-29 Patel Naimish (Chief Medical Officer) Sale 3,932 35.94 141,316
2025-05-28 Patel Naimish (Chief Medical Officer) Option Ex 10,000 .00 0
2025-03-21 Bruno Julianne (Chief Operating Officer) Sale 1,714 41.23 70,668
2025-03-21 Prasad Raju (Chief Financial Officer) Sale 2,197 41.23 90,582
2025-03-21 Kasinger James R. (General Counsel and Secretary) Sale 3,185 41.23 131,317
2025-03-21 Kulkarni Samarth (Chief Executive Officer) Sale 10,031 41.23 413,578
2025-03-20 Bruno Julianne (Chief Operating Officer) Option Ex 3,750 .00 0
2025-03-20 Prasad Raju (Chief Financial Officer) Option Ex 6,250 .00 0
2025-03-20 Kasinger James R. (General Counsel and Secretary) Option Ex 6,250 .00 0
2025-03-20 Kulkarni Samarth (Chief Executive Officer) Option Ex 19,688 .00 0
2025-03-17 Prasad Raju (Chief Financial Officer) Sale 3,762 41.80 157,251
2025-03-14 Prasad Raju (Chief Financial Officer) Option Ex 10,000 .00 0
2025-03-12 Bruno Julianne (Chief Operating Officer) Sale 190 43.32 8,230
2025-03-12 Kasinger James R. (General Counsel and Secretary) Sale 1,116 43.32 48,345
2025-03-12 Kulkarni Samarth (Chief Executive Officer) Sale 4,462 43.32 193,293
2025-03-11 Bruno Julianne (Chief Operating Officer) Sale 1,198 42.42 50,819
2025-03-11 Bruno Julianne (Chief Operating Officer) Option Ex 435 .00 0
2025-03-11 Kasinger James R. (General Counsel and Secretary) Sale 2,850 42.42 120,897
2025-03-11 Kasinger James R. (General Counsel and Secretary) Option Ex 2,250 .00 0
2025-03-11 Kulkarni Samarth (Chief Executive Officer) Sale 9,973 42.42 423,054
2025-03-11 Kulkarni Samarth (Chief Executive Officer) Option Ex 9,000 .00 0
2025-03-10 Bruno Julianne (Chief Operating Officer) Option Ex 2,399 .00 0
2025-03-10 Kasinger James R. (General Counsel and Secretary) Option Ex 5,500 .00 0
2025-03-10 Kulkarni Samarth (Chief Executive Officer) Option Ex 19,250 .00 0
2025-02-26 Greene John Buy 7,000 44.85 313,950
2025-02-19 Bruno Julianne (Chief Operating Officer) Sale 333 52.80 17,582
2025-02-19 Kasinger James R. (General Counsel and Secretary) Sale 1,947 52.80 102,801
2025-02-19 Kulkarni Samarth (Chief Executive Officer) Sale 25,288 54.00 1,379,361
2025-02-18 Bruno Julianne (Chief Operating Officer) Option Ex 650 .00 0
2025-02-18 Kasinger James R. (General Counsel and Secretary) Sale 9,595 53.85 516,690
2025-02-18 Kasinger James R. (General Counsel and Secretary) Option Ex 3,825 .00 0
2025-02-18 Kulkarni Samarth (Chief Executive Officer) Sale 11,640 55.05 640,782
2025-02-18 Kulkarni Samarth (Chief Executive Officer) Option Ex 13,250 .00 0
2025-02-16 Kasinger James R. (General Counsel and Secretary) Option Ex 20,000 .00 0
2024-12-02 Kulkarni Samarth (Chief Executive Officer) Sale 15,000 55.10 826,560
2024-11-11 Kulkarni Samarth (Chief Executive Officer) Sale 30,000 55.85 1,675,500
2024-10-14 Kasinger James R. (General Counsel and Secretary) Sale 1,089 46.28 50,398
2024-10-14 Kulkarni Samarth (Chief Executive Officer) Sale 4,293 46.28 198,680
2024-10-13 Kasinger James R. (General Counsel and Secretary) Option Ex 2,113 .00 0
2024-10-13 Kulkarni Samarth (Chief Executive Officer) Option Ex 8,333 .00 0
2024-06-21 Bruno Julianne (Chief Operating Officer) Sale 3,366 56.09 188,798
2024-06-20 Bruno Julianne (Chief Operating Officer) Option Ex 7,000 .00 0
2024-04-15 Kulkarni Samarth (Chief Executive Officer) Sale 19,582 60.14 1,177,681
2024-04-15 Kulkarni Samarth (Chief Executive Officer) Option Ex 19,582 19.12 374,407
2024-03-15 Prasad Raju (Chief Financial Officer) Sale 3,524 72.69 256,159
2024-03-15 Kulkarni Samarth (Chief Executive Officer) Sale 20,000 72.52 1,450,300
2024-03-15 Kulkarni Samarth (Chief Executive Officer) Option Ex 20,000 19.12 382,400
2024-03-14 Prasad Raju (Chief Financial Officer) Option Ex 10,000 .00 0
2024-03-12 Kasinger James R. (General Counsel and Secretary) Sale 1,146 74.44 85,308
2024-03-12 Kulkarni Samarth (Chief Executive Officer) Sale 4,583 74.44 341,158
2024-03-11 Kasinger James R. (General Counsel and Secretary) Sale 2,801 78.26 219,206
2024-03-11 Kasinger James R. (General Counsel and Secretary) Option Ex 2,250 .00 0
2024-03-11 Kulkarni Samarth (Chief Executive Officer) Sale 9,802 78.26 767,104
2024-03-11 Kulkarni Samarth (Chief Executive Officer) Option Ex 9,000 .00 0
2024-03-10 Kasinger James R. (General Counsel and Secretary) Option Ex 5,500 .00 0
2024-03-10 Kulkarni Samarth (Chief Executive Officer) Option Ex 19,250 .00 0
2024-02-20 Kasinger James R. (General Counsel and Secretary) Sale 1,913 79.67 152,408
2024-02-20 Kulkarni Samarth (Chief Executive Officer) Sale 6,370 79.67 507,497
2024-02-18 Kasinger James R. (General Counsel and Secretary) Option Ex 3,825 .00 0
2024-02-18 Kulkarni Samarth (Chief Executive Officer) Option Ex 13,250 .00 0
2024-02-15 Kulkarni Samarth (Chief Executive Officer) Sale 20,000 80.88 1,617,580
2024-02-15 Kulkarni Samarth (Chief Executive Officer) Option Ex 20,000 19.12 382,400
2024-01-29 Kulkarni Samarth (Chief Executive Officer) Sale 50,000 60.80 3,040,050
2024-01-29 Kulkarni Samarth (Chief Executive Officer) Option Ex 50,000 19.12 956,000
2024-01-16 Kulkarni Samarth (Chief Executive Officer) Sale 20,000 62.50 1,250,060
2024-01-16 Kulkarni Samarth (Chief Executive Officer) Option Ex 20,000 19.12 382,400
2023-05-30 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 65.13 1,628,350
2023-05-30 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 19.12 478,000
2023-05-23 Morrow Phuong Khanh (Chief Medical Officer) Option Ex 6,938 .00 0
2023-04-25 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 50.97 1,274,350
2023-04-25 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 19.12 478,000
2023-03-29 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 44.58 1,114,475
2023-03-29 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 19.12 478,000
2023-03-11 Kasinger James R. (General Counsel and Secretary) Option Ex 2,250 .00 0
2023-03-11 Kulkarni Samarth (Chief Executive Officer) Option Ex 9,000 .00 0
2023-03-10 Kasinger James R. (General Counsel and Secretary) Option Ex 2,833 .00 0
2023-03-10 Kulkarni Samarth (Chief Executive Officer) Option Ex 11,833 .00 0
2023-02-27 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 48.49 1,212,350
2023-02-27 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 19.12 478,000
2023-02-18 Smith Brendan (Chief Financial Officer) Option Ex 3,825 .00 0
2023-02-18 Kasinger James R. (General Counsel and Secretary) Option Ex 3,825 .00 0
2023-02-18 Kulkarni Samarth (Chief Executive Officer) Option Ex 13,250 .00 0
2023-01-27 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 51.07 1,276,775
2023-01-27 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 19.12 478,000
2022-12-28 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 41.13 1,028,350
2022-12-28 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 19.12 478,000
2022-12-06 Kulkarni Samarth (Chief Executive Officer) Option Ex 58,233 1.81 105,401
2022-12-03 Kasinger James R. (General Counsel and Secretary) Option Ex 6,667 .00 0
2022-12-03 Kulkarni Samarth (Chief Executive Officer) Option Ex 40,000 .00 0
2022-11-28 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 54.61 1,365,275
2022-11-28 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 19.12 478,000
2022-10-14 Smith Brendan (Chief Financial Officer) Option Ex 3,750 .00 0
2022-09-28 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 64.77 1,619,350
2022-09-28 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 16.21 405,250
2022-08-29 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 66.92 1,672,975
2022-08-29 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 16.21 405,250
2022-07-27 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 76.63 1,915,850
2022-07-27 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 14.39 359,750
2022-06-29 Kulkarni Samarth (Chief Executive Officer) Sale 25,000 61.87 1,546,825
2022-06-29 Kulkarni Samarth (Chief Executive Officer) Option Ex 25,000 12.57 314,250
2022-03-11 Klein Lawrence Otto (CBO & COO) Option Ex 3,000 .00 0
2022-03-11 Kasinger James R. (General Counsel and Secretary) Option Ex 2,250 .00 0
2022-03-11 Kulkarni Samarth (Chief Executive Officer) Option Ex 9,000 .00 0
2022-03-10 Klein Lawrence Otto (CBO & COO) Option Ex 4,584 .00 0
2022-03-10 Kasinger James R. (General Counsel and Secretary) Option Ex 2,834 .00 0
2022-03-10 Kulkarni Samarth (Chief Executive Officer) Option Ex 11,834 .00 0
2021-12-20 Kulkarni Samarth (Chief Executive Officer) Option Ex 17,750 1.81 32,127
2021-12-03 Klein Lawrence Otto (CBO & COO) Option Ex 26,667 .00 0
2021-12-03 Ho Tony W (Executive VP, Head of R&D) Option Ex 26,667 .00 0
2021-12-03 Kasinger James R. (General Counsel and Secretary) Option Ex 13,333 .00 0
2021-12-03 Kulkarni Samarth (Chief Executive Officer) Option Ex 80,000 .00 0
2021-12-02 Kasinger James R. (General Counsel and Secretary) Option Ex 7,342 13.62 99,998
2021-10-15 Kulkarni Samarth (Chief Executive Officer) Option Ex 33,000 1.81 59,730
2021-09-10 Klein Lawrence Otto (CBO & COO) Option Ex 10,000 .00 0
2021-09-10 Kasinger James R. (General Counsel and Secretary) Option Ex 10,000 .00 0
2021-08-06 Tomsicek Michael John (Chief Financial Officer) Sale 25,000 138.84 3,471,000
2021-08-06 Tomsicek Michael John (Chief Financial Officer) Option Ex 25,000 17.75 443,750
2021-08-05 Kulkarni Samarth (Chief Executive Officer) Sale 28,500 128.73 3,668,919
2021-08-05 Kulkarni Samarth (Chief Executive Officer) Option Ex 28,500 12.57 358,245
2021-08-04 Kulkarni Samarth (Chief Executive Officer) Sale 1,500 125.02 187,530
2021-08-04 Kulkarni Samarth (Chief Executive Officer) Option Ex 1,500 12.57 18,855
2021-07-19 Bolzon Bradley J Phd (Director) Sale 10,000 127.03 1,270,340
2021-06-30 Novak Rodger (President) Sale 25,000 165.00 4,125,000
2021-06-21 Novak Rodger (President) Sale 25,000 128.07 3,201,675
2021-06-11 Bolzon Bradley J Phd (Director) Sale 10,000 127.64 1,276,400
2021-03-22 Bolzon Bradley J Phd (Director) Sale 30,374 132.28 4,017,963
2021-03-10 Klein Lawrence Otto (CBO & COO) Option Ex 4,583 .00 0
2021-03-10 Ho Tony W (Executive VP, Head of R&D) Option Ex 4,583 .00 0
2021-03-10 Kasinger James R. (General Counsel and Secretary) Option Ex 2,833 .00 0
2021-03-10 Kulkarni Samarth (Chief Executive Officer) Option Ex 11,833 .00 0
2021-03-10 Tomsicek Michael John (Chief Financial Officer) Option Ex 2,833 .00 0
2021-03-05 Ho Tony W (Executive VP, Head of R&D) Option Ex 3,333 .00 0
2021-02-19 Bolzon Bradley J Phd (Director) Sale 171,003 149.99 25,648,568
2021-01-19 Kasinger James R. (General Counsel and Secretary) Sale 27,500 205.45 5,649,820
2021-01-19 Kasinger James R. (General Counsel and Secretary) Option Ex 27,500 51.49 1,415,975
2021-01-15 Klein Lawrence Otto (CBO & COO) Sale 25,000 215.28 5,381,950
2021-01-15 Klein Lawrence Otto (CBO & COO) Option Ex 25,010 13.50 337,635
2021-01-15 Kulkarni Samarth (Chief Executive Officer) Sale 20,000 214.49 4,289,700
2021-01-15 Kulkarni Samarth (Chief Executive Officer) Option Ex 20,000 1.81 36,200
2020-12-29 Kulkarni Samarth (Chief Executive Officer) Option Ex 13,800 1.81 24,978
2020-12-21 Ho Tony W (Executive VP, Head of R&D) Sale 23,551 149.69 3,525,349
2020-12-21 Ho Tony W (Executive VP, Head of R&D) Option Ex 23,551 16.90 398,011
2020-12-16 Bolzon Bradley J Phd (Director) Sale 15,000 149.12 2,236,785
2020-12-10 Kulkarni Samarth (Chief Executive Officer) Sale 20,000 142.92 2,858,320
2020-12-10 Kulkarni Samarth (Chief Executive Officer) Option Ex 20,000 1.81 36,200
2020-12-10 Bolzon Bradley J Phd (Director) Sale 33,000 142.54 4,703,754
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of CRSP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Crispr Therapeutics Ag (symbol CRSP, CIK number 1674416) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.